Exploratory study of prediction marker for efficacy and safety of TBI-1201

Exploratory study of prediction marker for efficacy and safety of TBI-1201 - Exploratory study of TBI-1201

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033711

Enrollment

Registered

2018-09-10

Start date

2019-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having enrolled to TBI-1201 clinical trial

Exclusion criteria

Exclusion criteria: Not having enrolled to TBI-1201 clinical trial

Design outcomes

Primary

Measure	Time frame
Cytokine analysis Immune response analysis Image diagnosis data	—

Countries

Japan

Contacts

Public ContactShinichi Kageyama

Mie University Graduate School of Medicine Immuno-Gene Therapy

kageyama@clin.medic.mie-u.ac.jp059-231-5684

Outcome results